Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Microbes and infection

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S1286-4579(00)01349-6PMID 11226851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.

  2009cited by this paper
• Changes in serotype caused by cell to cell contact between different Pseudomonas aeruginosa strains from cystic fibrosis patients.

  2009cited by this paper
• Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.

  2009cited by this paper
• Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.

  2009cited by this paper
• Alterations inPseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics

  2008cited by this paper
• The effect of ultrasonic frequency upon enhanced killing ofP. aeruginosa biofilms

  2007cited by this paper
• [Pseudomonas aeruginosa infection].

  2002cited by this paper
• Molecular Mechanisms of Fluoroquinolone Resistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

  2000cited by this paper
• The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type

  2000cited by this paper
• Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment.

  2000cited by this paper
• Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa.

  2000cited by this paper
• High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

  2000cited by this paper
• Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

  2000influential reference
• Bacterial Quorum Sensing in Pathogenic Relationships

  2000cited by this paper
• Photomechanical Drug Delivery into Bacterial Biofilms

  2000cited by this paper
• Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.

  1999cited by this paper
• Changing Epidemiology of Pseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974–1995)

  1999cited by this paper
• Robbins device in biofilm research.

  1999cited by this paper
• Avidity of anti-P aeruginosaantibodies during chronic infection in patients with cystic fibrosis

  1999cited by this paper
• Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

  1999cited by this paper
• Handbook of Animal Models of Infection

  1999cited by this paper
• The involvement of cell-to-cell signals in the development of a bacterial biofilm.

  1998cited by this paper
• Role of Flagella in Pathogenesis ofPseudomonas aeruginosa Pulmonary Infection

  1998cited by this paper
• In Situ Gene Expression in Mixed-Culture Biofilms: Evidence of Metabolic Interactions between Community Members

  1998cited by this paper
• Long-term azithromycin may improve lung function in children with cystic fibrosis.

  1998cited by this paper
• The Pseudomonas aeruginosaQuorum-Sensing Signal MoleculeN-(3-Oxododecanoyl)-l-Homoserine Lactone Has Immunomodulatory Activity

  1998cited by this paper
• Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice

  1997cited by this paper
• Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats

  1997cited by this paper
• Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.

  1997cited by this paper
• Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology

  1997cited by this paper
• Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

  1997influential reference
• Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection.

  1997cited by this paper
• The influence of allotypes on the IgG subclass response to chromosomal β‐lactamase of Pseudomonas aeruginosa in cystic fibrosis patients

  1997cited by this paper
• Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin.

  1996cited by this paper
• In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.

  1996cited by this paper
• Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals

  1996cited by this paper
• Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa.

  1996cited by this paper
• Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

  1996cited by this paper
• Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.

  1996cited by this paper
• The efficacy of antibiotics enhanced by electrical currents against Pseudomonas aeruginosa biofilms.

  1996cited by this paper
• Interferon‐gamma (IFN‐γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats

  1996influential reference
• Improved survival in the Danish center‐treated cystic fibrosis patients: Results of aggressive treatment

  1996cited by this paper
• Theoretical aspects of antibiotic diffusion into microbial biofilms

  1996cited by this paper
• Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.

  1995cited by this paper
• The Immune Response to Bacterial Biofilms

  1995cited by this paper
• Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.

  1995cited by this paper
• Airway biofilm disease: Clinical manifestations and therapeutic possibilities using macrolides

  1995cited by this paper
• A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.

  1995cited by this paper
• Effect of high-dose ibuprofen in patients with cystic fibrosis.

  1995cited by this paper
• Seventy years in the service of science 1924–1994

  1994cited by this paper
• Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

  1994cited by this paper
• In vitro and in vivo changes of serotype in Pseudomonas aeruginosa isolates by anti-pseudomonal drugs.

  1994cited by this paper
• Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center

  1994cited by this paper
• Allotypes of α1‐antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

  1994cited by this paper
• Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards

  1994influential reference
• Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.

  1994cited by this paper
• Biofilms, the customized microniche

  1994influential reference
• Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa.

  1993cited by this paper
• Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.

  1993cited by this paper
• Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

  1993cited by this paper
• Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis

  1993cited by this paper
• Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin

  1993cited by this paper
• Ecology and Epidemiologyof Pseudomonas aeruginosa

  1993cited by this paper
• Therapeutic possibilities for diffuse panbronchiolitis.

  1993cited by this paper
• Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.

  1993cited by this paper
• Pseudomonas aeruginosa as an Opportunistic Pathogen

  1993cited by this paper
• Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro.

  1993cited by this paper
• Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis.

  1993cited by this paper
• Effect of subinhibitory concentrations of Ciprofloxacin and gentamicin on the adherence of Pseudomonas aeruginosa to Vero cells and voided uroepithelial cells.

  1993cited by this paper
• Transport of 1‐μm latex particles in pseudomonas aeruginosa biofilms

  1993cited by this paper
• Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

  1993cited by this paper
• Pathogenesis of cystic fibrosis.

  1993cited by this paper
• Transport of 1-microm latex particles in pseudomonas aeruginosa biofilms.

  1993cited by this paper
• Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis.

  1993cited by this paper
• Pathogenesis of cystic fibrosis

  1993cited by this paper
• Modification of some markers of inflammation during treatment for acute respiratory exacerbation in cystic fibrosis

  1992cited by this paper
• Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

  1992cited by this paper
• Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection

  1992cited by this paper
• Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.

  1992cited by this paper
• Susceptibility of biofilm cells of Pseudomonas aeruginosa to bactericidal actions of whole blood and serum.

  1992cited by this paper
• Effect of acute changes in glomerular filtration rate on Na+/H+ exchange in rat renal cortex.

  1992cited by this paper
• Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy

  1992cited by this paper
• LOCALIZATION OF COMPONENTS FROM THE PLASMINOGEN ACTIVATION SYSTEM IN MAMMALIAN TISSUES

  1992cited by this paper
• Polyacrylamide gel electrophoresis analysis of lipopolysaccharide from Pseudomonas aeruginosa growing planktonically and as biofilm.

  1992influential reference
• Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.

  1992cited by this paper
• Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.

  1992cited by this paper
• Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms

  1992cited by this paper
• Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin

  1992cited by this paper
• High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment

  1992cited by this paper
• Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection.

  1991cited by this paper
• Pseudomonas aeruginosa exoenzyme S is an adhesion

  1991cited by this paper
• Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.

  1991cited by this paper
• Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa.

  1991cited by this paper
• Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

  1991cited by this paper
• Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.

  1991cited by this paper
• Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm

  1991cited by this paper
• A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan.

  1991cited by this paper
• Optical sectioning of microbial biofilms

  1991cited by this paper
• Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients

  1991cited by this paper
• Aerosol α1 -antitrypsin treatment for cystic fibrosis

  1991cited by this paper

• Nanoscience Approaches in Treating Urinary Tract Infection with Existing Antibiotic Therapy

  2025cites this paper
• Development and Characterization of a Collagen-Based Three-Dimensional In Vitro Model to Mimic Biofilm Formation in a Wound Bed.

  2025cites this paper
• Hydrogel-based drug delivery systems for localized eradication of bacterial biofilms: Advances, challenges and future directions.

  2025cites this paper
• Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis

  2025cites this paper
• Targeting intracellular of populations Pseudomonas aeruginosa with peptide-mimetic therapies: individual efficacy and synergistic rescue of obsolete antibiotics

  2025cites this paper
• ROS-induced allosteric regulation of NikR coordinates HP0910-mediated OMP2 methylation to modulate H. pylori biofilm dynamics and therapeutic targeting.

  2025cites this paper
• Myxinidin-analogs able to sequester Fe(III): Metal-based gun to combat Pseudomonas aeruginosa biofilm.

  2024cites this paper
• Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions

  2024cites this paper
• A Semisynthetic Oligomannuronic Acid-Based Glycoconjugate Vaccine against Pseudomonas aeruginosa

  2024cites this paper
• The biofilm proteome of Staphylococcus aureus and its implications for therapeutic interventions to biofilm-associated infections.

  2024cites this paper
• Dispersal of Pseudomonas aeruginosa biofilm using TDS97 bacteriophage and recombinant alginate lyase enzyme

  2024cites this paper
• Rational design of PspAlgL to improve its thermostability and anti-biofilm activity against Pseudomonas aeruginosa.

  2024cites this paper
• Biofilms: Mechanisms of Formation and Strategies for Control in Clinical Settings

  2024cites this paper
• Nanoparticle-based platforms for targeted drug delivery to the pulmonary system as therapeutics to curb cystic fibrosis: A review.

  2023cites this paper
• Interactions between quorum sensing/quorum quenching and virulence genes may affect coral health by regulating symbiotic bacterial community.

  2023cites this paper
• Liposomal Antibiotics for the Treatment of Infectious Diseases

  2023cites this paper
• Monitoring biofilm growth and dispersal in real-time with impedance biosensors

  2023cites this paper
• Effects of antibiotic treatment and phagocyte infiltration on development of Pseudomonas aeruginosa biofilm—Insights from the application of a novel PF hydrogel model in vitro and in vivo

  2022cites this paper
• Murine burn lesion model for studying acute and chronic wound infections

  2022cites this paper
• Biofilm and Small Colony Variants—An Update on Staphylococcus aureus Strategies toward Drug Resistance

  2022cites this paper
• Study of Natural and Modified Green Tea Polyphenols; GTP, LTP, EGCG, and EGCG-Stearate on Spore Germination, Biofilm Formation and Synergistic Effect on Antibiotics

  2022cites this paper
• The Role of Staphylococcal Biofilm on the Surface of Implants in Orthopedic Infection

  2022cites this paper
• Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis

  2022cites this paper
• Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance Pseudomonas aeruginosa isolated from the clinical specimen

  2022cites this paper
• An Overview of Biofilm Formation–Combating Strategies and Mechanisms of Action of Antibiofilm Agents

  2022cites this paper
• Betaine-urea deep eutectic solvent improves imipenem antibiotic activity

  2022cites this paper
• Growing emergence of drug-resistant Pseudomonas aeruginosa and attenuation of its virulence using quorum sensing inhibitors: A critical review

  2021cites this paper
• The effects of LL-37 on virulence factors related to the quorum sensing system of Pseudomonas aeruginosa

  2021cites this paper
• Novel Hybrid Peptide Cathelicidin 2 (1-13)-Thymopentin (TP5) and Its Derived Peptides with Effective Antibacterial, Antibiofilm, and Anti-Adhesion Activities

  2021cites this paper
• Inhibition of Methicillin Resistant Staphylococcus aureus Biofilm by Ethanol Extracts of Sauropus androgynus and Solanum torvum

  2021cites this paper
• Immune Responses to Pseudomonas aeruginosa Biofilm Infections

  2021cites this paper
• Destructing biofilms by cationic dextran through phase transition.

  2021cites this paper
• Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model.

  2021cites this paper
• Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges

  2021cites this paper
• Functional Nanomaterials and 3D-Printable Nanocomposite Hydrogels for Enhanced Cell Proliferation and for the Reduction of Bacterial Biofilm Formation.

  2021cites this paper
• Biofilm and Antimicrobial Resistance

  2021cites this paper
• CANADIAN CONSENSUS STATEMENT ON AEROSOLIZED ANTIBIOTIC USE IN CYSTIC FIBROSIS

  2020cites this paper
• The biofilm‐associated bacterial infections unrelated to indwelling devices

  2020cites this paper
• The Impact of Pf Bacteriophages on the Fitness of Pseudomonas aeruginosa; A Mathematical Modeling Approach

  2020cites this paper
• The importance of intracellular bacterial biofilm in infectious diseases.

  2020cites this paper
• Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies

  2020cites this paper
• Quantitative mapping of mRNA 3’ ends in Pseudomonas aeruginosa reveals a pervasive role for premature 3’ end formation in response to azithromycin

  2020cites this paper
• The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin

  2020cites this paper
• Bacterial Biofilm and its Role in the Pathogenesis of Disease

  2020cites this paper
• Combating Biofilm and Quorum Sensing: A New Strategy to Fight Infections

  2019cites this paper
• Bacterial fitness in chronic wounds appears to be mediated by the capacity for high-density growth, not virulence or biofilm functions

  2019cites this paper
• Assembly of Divalent Ligands and Their Effect on Divalent Binding to Pseudomonas aeruginosa Lectin LecA

  2019cites this paper
• Clinical Use of Colistin in Biofilm-Associated Infections.

  2019cites this paper
• Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier.

  2019cites this paper
• Designing quorum sensing inhibitors of Pseudomonas aeruginosa utilizing FabI: an enzymic drug target from fatty acid synthesis pathway

  2019cites this paper
• Preserving efficacy of glycopeptide antibiotics during nano-encapsulation in liposomes.

  2019cites this paper
• The emergence of biofilms : Computational and experimental studies

  2019cites this paper
• University of Antibacterial effect of graphene oxide (GO) nanoparticles against Pseudomonas putida biofilm of variable age

  2019cites this paper
• Antimicrobial activities of Asian ginseng, American ginseng, and notoginseng

  2019cites this paper
• Antibacterial effect of graphene oxide (GO) nano-particles against Pseudomonas putida biofilm of variable age

  2019cites this paper
• Isolation and identification of Pandoraea spp. From bronchoalveolar lavage of cystic fibrosis patients in Iran

  2019cites this paper
• Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin

  2019cites this paper
• DEVELOPING LIPOSOMES FOR ANTIBIOTIC ENCAPSULATION

  2019cites this paper
• Factors affecting biofilm formation as seed transmission mechanism of cowpea bacteria blight induced by Xanthomonas axonopodis pv vignicola (Burkholder) Dye

  2018cites this paper
• Deficient Lipid A Remodeling by the arnB Gene Promotes Biofilm Formation in Antimicrobial Peptide Susceptible Pseudomonas aeruginosa.

  2018cites this paper
• Biofilm inhibiting activity of betacyanins from red pitahaya (Hylocereus polyrhizus) and red spinach (Amaranthus dubius) against Staphylococcus aureus and Pseudomonas aeruginosa biofilms

  2018cites this paper
• Microfouling inhibition of human nosocomial pathogen Pseudomonas aeruginosa using marine cyanobacteria.

  2018cites this paper
• Protective role of the vulture facial skin and gut microbiomes aid adaptation to scavenging

  2018cites this paper
• Imaging N-Acyl Homoserine Lactone Quorum Sensing In Vivo.

  2018cites this paper
• Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa

  2018cites this paper
• Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules

  2018cites this paper
• Title High -lactamase levels change the pharmacodynamics of -lactam antibiotics in pseudomonas aeruginosa biofilms

  2018cites this paper
• An Unusual Neck Swelling Presenting 19 Years Post Anterior Cervical Surgery

  2017cites this paper
• Over-Expression and Immunogenicity of Outer Membrane Protein L (OprL) of Pseudomonas aeruginosa

  2017cites this paper
• Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates

  2017cites this paper
• Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action

  2017cites this paper
• Hyperoside inhibits biofilm formation of Pseudomonas aeruginosa.

  2017cites this paper
• Biofilms and host response – helpful or harmful

  2017cites this paper
• The Role of Bacterial Biofi lms in Chronic Infections

  2017cites this paper
• Investigation of the effects of Pseudomonas aeruginosa cell signalling on host-pathogen interactions during infection

  2017cites this paper
• Eficacia de dos soluciones multipropósito frente a biofilms de Pseudomonas aeruginosa inducidos in vitro en lentes de contacto blandos

  2017cites this paper
• One-step purification and characterization of alginate lyase from a clinical Pseudomonas aeruginosa with destructive activity on bacterial biofilm

  2017cites this paper
• Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases

  2017cites this paper
• Treatment of skin and soft tissue infections caused by Pseudomonas aeruginosa—A review of our experiences with citric acid over the past 20 years

  2017cites this paper
• Bacterial Biofilm and Antibiotic Resistance

  2017cites this paper
• Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin

  2017cites this paper
• Potential applications of nonthermal plasmas against biofilm‐associated micro‐organisms in vitro

  2017cites this paper
• Poly (ε-lysine) dendrons as effective modulators of virulence and biofilm formation in Pseudomonas aeruginosa

  2016cites this paper
• HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.

  2016cites this paper
• Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.

  2016cites this paper
• Interference Competition Among Household Strains of Pseudomonas

  2016cites this paper
• The inhibition of Pseudomonas aeruginosa biofilm formation by micafungin and the enhancement of antimicrobial agent effectiveness in BALB/c mice

  2016cites this paper
• Interactions between Pseudomonas aeruginosa bacteria and corneal fibroblasts in human microbial keratitis

  2016influential citation
• Synthesis, antibacterial and anti-MRSA activity, in vivo toxicity and a structure-activity relationship study of a quinoline thiourea.

  2016cites this paper
• Dynamics of oral biofilms associated with mechanical ventilation

  2016cites this paper
• Possible mechanisms of Pseudomonas aeruginosa-associated lung disease.

  2016cites this paper
• Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilms.

  2016cites this paper
• Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats

  2016cites this paper
• Genome-wide survey of Pseudomonas aeruginosa PA14 reveals a role for the glyoxylate pathway and extracellular proteases in the limited utilization of mucin

  2016cites this paper
• A Study on the Effect of Ethidium_Bromide on Virulence Factors ( Protease and Biofilm Formation ) by Klebsiella Pneamoniae Isolated from Different Clinical Sources

  2016cites this paper
• The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms

  2016cites this paper
• Antibacterial Efficiency of Hydroxyapatite Biomaterials with Biodegradable Polylactic Acid and Polycaprolactone Polymers Saturated with Antibiotics / Bionoārdāmu Polimēru Saturošu Un Ar Antibiotiskajām Vielām Piesūcinātu Biomateriālu Antibakteriālās Efektivitātes Noteikšana

  2016cites this paper
• Nanoparticle Induced Suppression of Microbial Biofilm

  2016cites this paper
• Investigation of the enhanced antimicrobial activity of combination dry powder inhaler formulations of lactoferrin.

  2016cites this paper
• Rabbit Serum Raised against P. aeruginosa Biofilm Exhibit Significant Biofilm Reduction and Removal Activity

  2016cites this paper